Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women.
about
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidityAntibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidityProphylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality.Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation.Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm deliveryRandomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocolAerobic vaginitis in pregnancy.The preterm placental microbiome varies in association with excess maternal gestational weight gain.Preconception care between pregnancies: the content of internatal care.The vaginal microbiome in health and diseaseRecurrent hope for the treatment of preterm delivery.A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results.Antimicrobials for preterm birth prevention: an overview.Recent pharmacological advances in the treatment of preterm membrane rupture, labour and delivery.Investigation of metronidazole use during pregnancy and adverse birth outcomes.Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysisExamining the relationship between positive mid-gestational fetal fibronectin assays and histological evidence of acute placental inflammation.Care for women with prior preterm birth.Additional antibiotic use and preterm birth among bacteriuric and nonbacteriuric pregnant women.Trichomonas vaginalis infection.Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and ZambiaEffect of antibiotic exposure on Nugent score among pregnant women with and without bacterial vaginosis.Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes.A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranesAntibiotic Therapy for Premature Rupture of Membranes and Preterm Labor and Effect on Fetal Outcome.Timing and risk factors of maternal complications of cesarean section.Association of prenatal antibiotics with foetal size and cord blood leptin and adiponectin.Drug therapy during pregnancy: implications for dental practice.Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches.A randomized controlled trial of adjunctive erythromycin in women with idiopathic preterm labor.Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.Preterm birth: avenues for future study
P2860
Q24186506-8432E5F1-3797-464A-831C-1521DED7B8DBQ24187066-3AA6D002-CFDC-4588-BAAF-250B0443D319Q30879958-D45D3697-2B8D-41A2-97B6-C148C934B607Q33666247-301DE5AA-532B-41D7-8AF8-70DADAD8EDABQ33779297-ED4A1B57-3B6C-45E2-95D0-5905F4D6AA98Q34025678-3B74ED4D-C6D2-451F-BC06-A339C6F789C5Q34192094-2A624853-203F-43FF-A3CB-09FAFFF7DDFAQ34456447-F3187627-60D3-4899-9C22-D0E7F99446E7Q35069417-3CB15208-AF93-4854-BB2D-86F8A2B4A501Q35243537-6ADD0B8F-A5A7-4C76-B600-FD0DC5F32372Q35594025-22A05B0B-B211-423C-BF2E-41DF71783F51Q35690055-3D9E6720-DBED-4252-8A97-E53F8AB7E6F3Q35810450-0B1CB1B1-15BB-41E3-8E4F-E361B2ED4AA6Q35871864-64F4FB31-0E49-418A-9553-D57A9E4BF7F6Q36172432-9FB0C61D-F306-4C38-9153-529B0238AD1FQ36487287-0C1AC284-1460-4C30-9916-DE0890DB701AQ36741391-200F708D-E609-49F3-959E-D9D53511A00EQ36829111-231813FF-F304-4837-B081-CB979792FF60Q36920212-B3D3B423-D11A-4EB2-A6D5-8F199727A04DQ36928780-4974172E-9BB6-4911-BA44-1DC83B253939Q37438124-6A370AFA-6D95-4662-A0B0-D0A8A119B0C9Q37467495-BB0875CE-BEDF-428D-BE20-8723A8FF6F2EQ37607702-F4B98A3F-CE0C-4B67-BEA6-A442AABADD5EQ37637664-1F35E0D5-9B10-4ACB-A761-AFCCAC14E09AQ37660617-49058A5A-36D7-42A0-9D5A-8E590287EACBQ37721825-A3DA8302-5905-49D1-A11F-18308C334E94Q40868840-EF464098-AD76-4443-BDCD-3EC5AA4045D8Q47438556-8B847EF2-420A-46AF-8E4F-52E15353BC06Q47961270-65298EC9-E60A-4BD8-94E3-A9A7BA827938Q48720305-C0D1902C-10BF-467B-88CB-F2172051975EQ50978345-6BA81442-6A93-4571-84D3-E4377934F9FEQ57477505-AD2EC381-1DF8-4B12-9DB9-F3EE0A25B954
P2860
Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Randomized clinical trial of m ...... al fibronectin-positive women.
@en
Randomized clinical trial of m ...... al fibronectin-positive women.
@nl
type
label
Randomized clinical trial of m ...... al fibronectin-positive women.
@en
Randomized clinical trial of m ...... al fibronectin-positive women.
@nl
prefLabel
Randomized clinical trial of m ...... al fibronectin-positive women.
@en
Randomized clinical trial of m ...... al fibronectin-positive women.
@nl
P2093
P1476
Randomized clinical trial of m ...... al fibronectin-positive women.
@en
P2093
Atef Moawad
Baha M Sibai
Donald Dudley
Donald McNellis
Elizabeth A Thom
J M Ernest
Jay D Iams
Kenneth J Leveno
Mary J O'Sullivan
Menachem Miodovnik
P304
P356
10.1016/S0029-7844(03)00172-8
P407
P433
P577
2003-05-01T00:00:00Z